Testing effectiveness (Phase 2)UnknownNCT00501332
What this trial is testing
Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy
Who this might be right for
Chemotherapy-Induced NeutropeniaBreast Cancer
Maxygen Holdings Ltd. 30